(A) Oval and elongated yeast-like structures in the deep dermis. (PAS, ×400). (B) Patient’s cat with nasal ulceration diagnosed as sporotrichosis. Only 10 published cases of PGLS were found in the ...
Pyoderma gangrenosum lesion regression after dapsone treatment. However, after two weeks, the patient’s hematological condition deteriorated, presenting with a hemoglobin level of 7 g/dL, white blood ...
InflaRx (NASDAQ:IFRX) is one of the best penny stocks under $1 to buy now. As May came to an end, InflaRx announced that its Phase 3 trial for vilobelimab in pyoderma gangrenosum/PG would be ...
A systematic review of 63 cases found that pyoderma gangrenosum (PG) during pregnancy or postpartum was often misdiagnosed, delaying treatment and leading to inappropriate interventions. Researchers ...
InflaRx (NASDAQ:IFRX) lost over half of its market cap in the premarket on Wednesday after the German biotech announced it would discontinue studies into its lead candidate, vilobelimab, against a ...
JENA, Germany, May 28, 2025 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the complement system, today announced that ...
Backers of Jena, Germany-based Inflarx NV have turned their attention to the rest of the pipeline after the stock-jolting news from an independent data monitoring committee (DMC) responsible for the ...
SPOKANE, Wash. – Ryan Becker, a Spokane resident, is battling an extremely rare skin condition known as pyoderma gangrenosum. After visits to the Mayo Clinic and Johns Hopkins, Becker has been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback